72715

Glutaryl-L-carnitine lithium salt

≥98.0% (TLC)

Manufacturer: Sigma Aldrich

CAS Number: 102636-82-8

Synonym(S): L-Carnitine lithium glutarate

Select a Size

Pack Size SKU Availability Price
10 MG 72715-10-MG In Stock ₹ 7,155.33
50 MG 72715-50-MG In Stock ₹ 28,404.80

72715 - 10 MG

₹ 7,155.33

In Stock

Quantity

1

Base Price: ₹ 7,155.33

GST (18%): ₹ 1,287.959

Total Price: ₹ 8,443.289

Quality Level

100

Assay

≥98.0% (TLC)

form

solid

optical activity

[α]/D -20±2°, c = 1 in H2O

impurities

≤10% water

color

white to off-white

storage temp.

2-8°C

SMILES string

C[N+](C)(C)C[C@H](OC(CCCC(O)=O)=O)CC([O-])=O.C

InChI

1S/C12H21NO6/c1-13(2,3)8-9(7-11(16)17)19-12(18)6-4-5-10(14)15/h9H,4-8H2,1-3H3,(H-,14,15,16,17)/t9-/m1/s1

InChI key

NXJAXUYOQLTISD-SECBINFHSA-N

Other Options

Image Product Name Manufacturer Price Range
50-186-1726
Sigma Aldrich Fine Chemicals Biosciences Glutaryl-L-carnitine lithium salt >=98.0% (TLC) | 102636-82-8 (free acid) | 10MG
Sigma Aldrich Fine Chemicals Biosciences ₹ 10,542.94
50-186-1727
Sigma Aldrich Fine Chemicals Biosciences Glutaryl-L-carnitine lithium salt >=98.0% (TLC) | 102636-82-8 (free acid) | 50MG
Sigma Aldrich Fine Chemicals Biosciences ₹ 41,647.55
72715
Glutaryl-L-carnitine lithium salt
Sigma Aldrich ₹ 7,155.33 - ₹ 28,404.80
AR0008OU
1-Propanaminium, 3-carboxy-2-(4-carboxy-1-oxobutoxy)-N,N,N-trimethyl-, inner salt, (2R)-
Aaron Chemicals LLC ₹ 8,010.00 - ₹ 37,202.00
AA10162
102636-82-8 | 1-Propanaminium, 3-carboxy-2-(4-carboxy-1-oxobutoxy)-N,N,N-trimethyl-, inner salt, (2R)-
A2B Chem ₹ 3,382.00 - ₹ 11,125.00

Related Products

Img

Sigma Aldrich

42623

≥97.0% (TLC)...

Img

Sigma Aldrich

42602

≥94.0% (HPLC), suitable for LC/MS...

Img

Sigma Aldrich

73097

≥95% (TLC)...

Img

Sigma Aldrich

A3128

≥98% (TLC)...

Img

Sigma Aldrich

B2522

>98% (TLC)...

Img

Sigma Aldrich

68264

≥97% (HPLC)...

Img

Sigma Aldrich

A5139

≥98%...

Img

Sigma Aldrich

A6376

≥99% (TLC), suitable for ligand bin...

Description

  • Biochem/physiol Actions: Increased formation and excretion of glutarylcarnitin results from a glutaryl-CoA dehydrogenase deficiency, an inborn error of lysine and tryptophan metabolism. Secondary carnitine depletion due to increased formation and urinary excretion of glutarylcarnitine is suggested to play an important role in the neuropathogenesis of glutaryl-CoA dehydrogenase deficiency, inducing excitotoxic neuronal damage and mitochondrial dysfunction.

SAFETY INFORMATION

WGK

WGK 3

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable